Vilma Petrikaitė

2.6k total citations
89 papers, 1.8k citations indexed

About

Vilma Petrikaitė is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Vilma Petrikaitė has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 23 papers in Organic Chemistry and 16 papers in Oncology. Recurrent topics in Vilma Petrikaitė's work include Synthesis and biological activity (13 papers), Enzyme function and inhibition (10 papers) and Phytochemicals and Antioxidant Activities (9 papers). Vilma Petrikaitė is often cited by papers focused on Synthesis and biological activity (13 papers), Enzyme function and inhibition (10 papers) and Phytochemicals and Antioxidant Activities (9 papers). Vilma Petrikaitė collaborates with scholars based in Lithuania, Italy and Ukraine. Vilma Petrikaitė's co-authors include Daumantas Matulis, M. Helena Vasconcelos, Mélanie A. G. Barbosa, Rúben F. Pereira, Cristina P. R. Xavier, Lina Baranauskienė, Jurgita Matulienė, Christian Celia, Lina Raudonė and Gabrielė Vilkickytė and has published in prestigious journals such as PLoS ONE, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Vilma Petrikaitė

83 papers receiving 1.8k citations

Peers

Vilma Petrikaitė
Comparison fields: 5 of 129
  • Molecular Biology 707
  • Organic Chemistry 355
  • Biomedical Engineering 354
  • Oncology 310
  • Biomaterials 230
Mehdi Rajabi United States
Rong Liu China
Abolfazl Barzegar Iran
David Y. Léger France
Konstantinos Dimas Greece
Jaspreet Kaur Dhanjal India
Ahmed M. Al‐Abd Egypt
Fatemeh Mosaffa Iran
Eleonora Turrini Italy
Viney Lather India
Mehdi Rajabi United States View profile →
Citations per field, relative to Vilma Petrikaitė
Vilma Petrikaitė · 1×
Citations per year, relative to Vilma Petrikaitė
Vilma Petrikaitė · 1×

Countries citing papers authored by Vilma Petrikaitė

Since Specialization
Citations

This map shows the geographic impact of Vilma Petrikaitė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilma Petrikaitė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilma Petrikaitė more than expected).

Fields of papers citing papers by Vilma Petrikaitė

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vilma Petrikaitė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilma Petrikaitė. The network helps show where Vilma Petrikaitė may publish in the future.

Co-authorship network of co-authors of Vilma Petrikaitė

This figure shows the co-authorship network connecting the top 25 collaborators of Vilma Petrikaitė. A scholar is included among the top collaborators of Vilma Petrikaitė based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilma Petrikaitė. Vilma Petrikaitė is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Novel 5-Oxopyrrolidine-3-carbohydrazides as Potent Protein Kinase Inhibitors: Synthesis, Anticancer Evaluation, and Molecular Modeling International Journal of Molecular Sciences Maryna Stasevych, Viktor Zvarych et al. 0
2 Gelation of different phases of probiotic-loaded water-in-oil-in-water emulsion to enhance probiotic survival stability International Journal of Food Science & Technology Vilma Petrikaitė, Aušra Šipailienė et al. 5
3 Biochemical diversity and anticancer potential of phenolic compounds in Sambucus nigra L. cultivars Applied Food Research Vilma Petrikaitė, Mindaugas Liaudanskas et al. 0
4 Nanosystems for myocardial ischemic injury theranostics Biochemical Pharmacology Vilma Petrikaitė et al. 0
5 The fabrication method impacts biological properties of microfibrous three-dimensional in vitro cell culture scaffolds and their applications in drug screening Materials Today Communications Darius Čiužas, Edvinas Krugly et al. 1
6 The Complex Regulation of Cytokinesis upon Abscission Checkpoint Activation Molecular Cancer Research Vilma Petrikaitė et al. 4
7 Synthesis and effect of 4-acetylphenylamine-based imidazole derivatives on migration and growth of 3D cultures of breast, prostate and brain cancer cells Scientific Reports Vytautas Mickevičius, Vilma Petrikaitė et al. 2
8 Short-chain fructooligosaccharides synthesis using a commercial enzyme complex from Aspergillus sp. and anti-cancer activity on HCT116 and HT-29 cell lines Food Bioscience Vilma Petrikaitė, Michail Syrpas et al. 4
9 The Effect of 4-(Dimethylamino)phenyl-5-oxopyrrolidines on Breast and Pancreatic Cancer Cell Colony Formation, Migration, and Growth of Tumor Spheroids International Journal of Molecular Sciences Vytautas Mickevičius, Vilma Petrikaitė et al. 3
10 Comparative In Vitro Study: Assessing Phytochemical, Antioxidant, Antimicrobial, and Anticancer Properties of Vaccinium macrocarpon Aiton and Vaccinium oxycoccos L. Fruit Extracts Pharmaceutics Valdimaras Janulis, Alvydas Pavilonis et al. 4
11 Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives International Journal of Molecular Sciences Ilona Jonuškienė, Kristina Kantminienė et al. 11
12 Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia International Journal of Molecular Sciences Elias Maccioni, Vilma Petrikaitė et al. 11
13 Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models Drug Resistance Updates Vilma Petrikaitė, Nicola d’Avanzo et al. 18
14 The Chemo-Sensitizing Effect of Doxorubicin of Apple Extract-Enriched Triterpenic Complex on Human Colon Adenocarcinoma and Human Glioblastoma Cell Lines Pharmaceutics Valdimaras Janulis, Vilma Petrikaitė et al. 3
15 Antioxidant, Anti-Inflammatory, and Cytotoxic Activity of Extracts from Some Commercial Apple Cultivars in Two Colorectal and Glioblastoma Human Cell Lines Antioxidants Vilma Petrikaitė, Mindaugas Liaudanskas et al. 13
16 Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models Bioorganic Chemistry Vytautas Mickevičius, Vilma Petrikaitė et al. 6
17 Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures Cancer Management and Research Vilma Petrikaitė et al. 34
18 A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging ACS Applied Materials & Interfaces Zehua Liu, Lina Baranauskienė et al. 42
19 Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90 PLoS ONE Egidijus Kazlauskas, Vilma Petrikaitė et al. 27
20 Antimikrobinių vaistų vartojimo įvertinimas ir palyginimas su jų racionalaus vartojimo rekomendacijomis Laba (Lietuvos akademinių bibliotekų direktorių asociacija) Romaldas Mačiulaitis, Vilma Petrikaitė et al. 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehdi Rajabi Breakdown of academic impact, for papers by Rong Liu Breakdown of academic impact, for papers by Abolfazl Barzegar Breakdown of academic impact, for papers by David Y. Léger Breakdown of academic impact, for papers by Konstantinos Dimas Breakdown of academic impact, for papers by Jaspreet Kaur Dhanjal Breakdown of academic impact, for papers by Ahmed M. Al‐Abd Breakdown of academic impact, for papers by Fatemeh Mosaffa Breakdown of academic impact, for papers by Eleonora Turrini Breakdown of academic impact, for papers by Viney Lather
Rankless by CCL
2026